Previous close | 1.9500 |
Open | 1.9400 |
Bid | 1.8800 x N/A |
Ask | 1.9500 x N/A |
Day's range | 1.8550 - 1.9400 |
52-week range | 1.7200 - 3.2100 |
Volume | |
Avg. volume | 238,315 |
Market cap | 677.108M |
Beta (5Y monthly) | 1.88 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.4200 |
Earnings date | 08 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 4.25 |
Key Insights The projected fair value for TerrAscend is CA$1.98 based on 2 Stage Free Cash Flow to Equity With CA$1.95...
TORONTO, June 17, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today announced the results of its annual meeting of shareholders held on June 17, 2024 (the "Meeting"). Common shareholders at the Meeting affirmatively approved the following resolutions: the election of Mr. Craig Collard, Ms. Ira Duarte, Mr. Ed Schutter, Ms. Kara DioGuardi and Mr. Jason Wild as directors of the Company;the ratificat
Prime location features a convenient drive-thru and an expanded floor planTORONTO, June 10, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today announced the opening of The Apothecarium Nottingham, the Company’s fourth retail location in Maryland and 39th dispensary nationwide. Located at 8241 Perry Hall Blvd, Nottingham, MD 21236, the dispensary replaces The Apothecarium Parkville and is now open